Does radiosurgery have a role in the management of oligodendrogliomas? Clinical article

Journal of Neurosurgery

Volumn 110, Issue 3, 2009, Pages 564-571

  Kano, Hideyuki ^a   Niranjan, Ajay ^a   Khan, Aftab ^a   Flickinger, John C ^a   Kondziolka, Douglas ^a   Lieberman, Frank ^a   Lunsford, L Dade ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Chemotherapy; Gamma knife; Oligodendroglioma; Radiation therapy; Stereotactic radiosurgery

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; SCHOOL CHILD; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; TUMOR BIOPSY; TUMOR GROWTH; TUMOR VOLUME; BRAIN TUMOR; MIDDLE AGED; MORTALITY; RADIOSURGERY;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 63849124111     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.5.17582     Document Type: Article

References (31)

1. Allam A, Radwi A, El Weshi A, Hassounah M: Oligodendroglioma: an analysis of prognostic factors and treatment results. Am J Clin Oncol 23:170-175, 2000
2. Bauman GS, Ino Y, Ueki K, Zlatescu MC, Fisher BJ, Macdonald DR, et al: Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 48:825-830, 2001
3. Bullard DE, Rawlings CE III, Phillips B, Cox EB, Schold SC Jr, Burger P, et al: Oligodendroglioma. An analysis of the value of radiation therapy. Cancer 60:2179-2188, 1987 (Pubitemid 17153480)
4. Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, et al: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12:2013-2021, 1994 (Pubitemid 24356016)
5. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, et al: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473-1479, 1998 (Pubitemid 28482012)
6. Chinot O: Chemotherapy for the treatment of oligodendroglial tumors. Semin Oncol 28 (4 Suppl):S13-S18, 2001
7. Combs SE, Schulz-Entner D, Thilmann C, Edler L, Debus J: Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma. Int J Radiat Oncol Biol Phys 62:797-802, 2005 (Pubitemid 40779771)
8. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710, 1993 (Pubitemid 23133591)
9. Daumas-Duport C, Tucker ML, Kolles H, Cervera P, Beuvon F, Varlet P, et al: Oligodendrogliomas. Part II: a new grading system based on morphological and imaging criteria. J Neurooncol 34:61-78, 1997 (Pubitemid 27270252)
10. Dehghani F, Schachenmayr W, Laun A, Korf HW: Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases. Acta Neuropathol 95:493-504, 1998
11. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585-2597, 1993
12. Gannett DE, Wisbeck WM, Silbergeld DL, Berger MS: The role of postoperative irradiation in the treatment of oligodendroglioma. Int J Radiat Oncol Biol Phys 30:567-573, 1994
13. Hadjipanayis CG, Kondziolka D, Gardner P, Niranjan A, Dagam S, Flickinger JC, et al: Stereotactic radiosurgery for pilocytic astrocytomas when multimodal therapy is necessary. J Neurosurg 97:56-64, 2002 (Pubitemid 36407896)
14. Heegaard S, Sommer HM, Broholm H, Broendstrup O: Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis. Cancer 76:1809-1813, 1995
15. Henderson KH, Shaw EG: Randomized trials of radiation therapy in adult low grade gliomas. Semin Radiat Oncol 11:145-151, 2001
16. Huncharek M, Muscat J: Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients. Anticancer Res 18:1303-1312, 1998 (Pubitemid 28234036)
17. Kros JM, Troost D, van Eden CG, van der Werf AJ, Uylings HB: Oligodendroglioma. A comparison of two grading systems. Cancer 61:2251-2259, 1994
18. Ludwig CL, Smith MT, Godfrey AD, Armbrustmacher VW: A clinicopathological study of 323 patients with oligodendrogliomas. Ann Neurol 19:15-21, 1986
19. Mørk SL, Lindegaard KF, Halvorsen TB, Lehmann EH, Solgaard T, Hatlevoll R, et al: Oligodendroglioma: incidence and biological behavior in a defined population. J Neurosurg 63:881-889, 1985
20. Nijjar TS, Simpson WJ, Gadalla T, McCartney M: The Princess Margaret Hospital experience (1958-1984). Cancer 71:4002-4006, 1993
21. Reifenberger G, Kros JM, Burger PC, Louis DN, Collins VP: Oligodendroglioma, in Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System, ed 2. Lyon: IARC Press, 2000, pp 56-61
22. Russell DS, Rubinstein LJ (eds): Pathology of Tumours of the Nervous System, ed 5. Baltimore: Williams & Wilkins, 1989
23. Sarkar A, Pollock BE, Brown PD, Gorman DA: Evaluation of gamma knife radiosurgery in the treatment of oligodendrogliomas and mixed oligodendroastrocytomas. J Neurosurg 97 (5 Suppl):653-656, 2002 (Pubitemid 35424363)
24. Schiffer D: Brain Tumors. Pathology, and Clinical References, ed 2. Berlin: Springer-Verlag, 1997
25. Schiffer D, Dutto A, Cavalla P, Bosone I, Chiò A, Villani R, et al: Prognostic factors in oligodendroglioma. Can J Neurol Sci 24:313-319, 1997 (Pubitemid 28064758)
26. Shaw EG, Scheithauer BW, O'Fallon JR, Davis DH: Mixed oligodendrogliomas: a survival and prognostic factor analysis. Neurosurgery 34:577-582, 1994
27. Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH: Oligodendroglioma: the Mayo Clinic experience. J Neurosurg 76:428-434, 1992
28. Sunyach MP, Pommier P, Martel Lafay I, Guyotat J, Ginestet G, Jouanneau E, et al: Conformal irradiation for pure and mixed oligodendroglioma: the experience of Centre Leon Berard Lyon. Int J Radiat Oncol Biol Phys 56:296-303, 2003 (Pubitemid 36403704)
29. van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, et al: Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985-990, 2005 (Pubitemid 41323034)
30. Westergaard L, Gjerris F, Klinken L: Prognostic factors in oligodendrogliomas. Acta Neurochir (Wien) 139:600-605, 1997 (Pubitemid 27298209)
31. Wharton SB, Hamilton FA, Chan WK, Chan KK, Anderson JR: Proliferation and cell death in oligodendrogliomas. Neuropathol Appl Neurobiol 24:21-28, 1998